Drugging the undruggable: Therapeutic implications of a novel pan-KRAS inhibitor for cancer biology
Dongsung Kim, Ph.D.
Postdoctoral Fellow, Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY
Department of Pharmacology
Click here for Zoom Or, go to https://upstate.zoom.us/join and enter meeting ID: 926 8881 8938 and password: 652629 Join from dial-in phone line: Dial: +1 646 876 9923 or +1 646 931 3860 Meeting ID: 926 8881 8938 Participant ID: Shown after joining the meeting. International numbers: https://upstate.zoom.us/u/apDtgsj8R